The Embryo Transfer Catheter consists of a soft, low-friction, flexible material, which promotes optimal positioning of the embryo and at the same time, guarantees the intrauterine protection of the ...

INVO Fertility, Inc. (Nasdaq: IVF) ("INVO” or the "Company”), a healthcare services fertility company focused on expanding access to advanced reproductive treatment through the establishment, ...

Progyny (PGNY) looks undervalued at 9.3x forward P/E, with strong cash flow, buybacks, and ~60% upside to $28—see the 2026–27 ...

TOKYO — Japan has approved ground-breaking stem-cell treatments for Parkinson's disease and severe heart failure, one of the manufacturers and media reports said on Friday, with the therapies expected ...

Progyny provides fertility and family-building benefits to an estimated 7.2 million covered lives through over 600 employers and plan sponsors nationwide. WFI’s participation in the Progyny network ...

IVF treatment does not appear to increase long-term risks of major cardiovascular disease or breast cancer, although outcomes ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...